#3739
Local tumor control in patients with neuroendocrine neoplasms treated with stereotactic ablative radiotherapy (SBRT)
Introduction:
Neuroendocrine neoplasms (NEN) represent a diverse group of malignancies. Anatomic origin, histology and biological behaviour vary extensively. The treatment armamentarium includes surgery (first choice when possible), systemic therapy and localised treatment modalities. The role of radiotherapy is not yet established, but studies indicate that local tumor control (LTC) can be achieved by high-dose radiotherapy. Stereotactic ablative radiotherapy (SBRT) is high doses of radiation delivered to a small target, with potential of achieving local tumor control.
Conference:
Presenting Author:
Authors:
Nygaard Dowler A,
Aggerholm Pedersen N,
Knap Marquard M,
Dam G,
Tabaksblat E,
Keywords:
neuroendocrine,
stereotactic radiotherapy,
sbrt,
local control,
#3552
Fatigue and quality of life in patients with neuroendocrine neoplasia
Introduction:
Neuroendocrine Neoplasms (NEN) are rare tumors and health related quality of life (HRQoL) may be modulated by the disease and the accompanying carcinoid syndrome seen especially in small intestinal NENs. Further, cancer related fatigue is one of the most common side effects of cancer and its treatments and may persist for years after treatment completion.
Conference:
Presenting Author:
Hummelshøj N
Authors:
Hummelshøj N,
Grønbæk H,
Bager P,
Tabaksblat E,
Dam G,
Keywords:
Neuroendocrine,
HRQoL,
Fatigue,
Patient reported outcome,
Carcinoid syndrome,
#2725
Upfront Surgery in Patients with High-Grade GEP NEN and MINEN: A Nordic Multicenter Study of 201 Patients
Introduction:
Surgery is the principal treatment for loco-regional gastroenteropancreatic (GEP) neuroendocrine tumors (NET). However, whether surgery is beneficial in high-grade neuroendocrine neoplasms (NEN) and mixed neuroendocrine-non neuroendocrine neoplasms (MiNEN) is not known.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Pommergaard H
Authors:
Pommergaard H,
Nielsen K,
Sorbye H,
Federspiel B,
Tabaksblat E,
Keywords:
surgery,
neuroendocrine carcinoma,
MiNEN,
neuroendocrine neoplasms,
survival,
gastroenteropancreatic,
